Potent Quinoline-Containing Combretastatin A-4 Analogues: Design, Synthesis, Antiproliferative, and Anti-Tubulin Activity

A novel series of quinoline derivatives of combretastatin A-4 incorporating rigid hydrazone and a cyclic oxadiazole linkers were synthesized and have demonstrated potent tubulin polymerization inhibitory properties. Many of these novel derivatives have shown significant antiproliferative activities...

Full description

Bibliographic Details
Main Authors: Tarek S. Ibrahim, Mohamed M. Hawwas, Azizah M. Malebari, Ehab S. Taher, Abdelsattar M. Omar, Niamh M. O’Boyle, Eavan McLoughlin, Zakaria K. Abdel-Samii, Yaseen A. M. M. Elshaier
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/13/11/393
id doaj-19ebe3e124bc42398900ea3767719fa5
record_format Article
spelling doaj-19ebe3e124bc42398900ea3767719fa52020-11-25T04:09:17ZengMDPI AGPharmaceuticals1424-82472020-11-011339339310.3390/ph13110393Potent Quinoline-Containing Combretastatin A-4 Analogues: Design, Synthesis, Antiproliferative, and Anti-Tubulin ActivityTarek S. Ibrahim0Mohamed M. Hawwas1Azizah M. Malebari2Ehab S. Taher3Abdelsattar M. Omar4Niamh M. O’Boyle5Eavan McLoughlin6Zakaria K. Abdel-Samii7Yaseen A. M. M. Elshaier8Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi ArabiaDepartment of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut 71524, EgyptDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi ArabiaDepartment of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut 71524, EgyptDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi ArabiaSchool of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Trinity Biomedical Sciences Institute, 152-160 Pearse Street, Dublin 2, IrelandSchool of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Trinity Biomedical Sciences Institute, 152-160 Pearse Street, Dublin 2, IrelandDepartment of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig 44519, EgyptDepartment of Organic and Medicinal Chemistry, Faculty of Pharmacy, University of Sadat City, 32958 Menoufia, EgyptA novel series of quinoline derivatives of combretastatin A-4 incorporating rigid hydrazone and a cyclic oxadiazole linkers were synthesized and have demonstrated potent tubulin polymerization inhibitory properties. Many of these novel derivatives have shown significant antiproliferative activities in the submicromolar range. The most potent compound,<b> 19h</b>, demonstrated superior IC<sub>50</sub> values ranging from 0.02 to 0.04 µM against four cancer cell lines while maintaining low cytotoxicity in MCF-10A non-cancer cells, thereby suggesting <b>19h</b>’s selectivity towards proliferating cancer cells. In addition to tubulin polymerization inhibition, <b>19h </b>caused cell cycle arrest in MCF-7 cells at the G2/M phase and induced apoptosis. Collectively, these findings indicate that <b>19h</b> holds potential for further investigation as a potent chemotherapeutic agent targeting tubulin.https://www.mdpi.com/1424-8247/13/11/393combretastatin A-4quinolinetubulinapoptosishydrazoneoxadiazole
collection DOAJ
language English
format Article
sources DOAJ
author Tarek S. Ibrahim
Mohamed M. Hawwas
Azizah M. Malebari
Ehab S. Taher
Abdelsattar M. Omar
Niamh M. O’Boyle
Eavan McLoughlin
Zakaria K. Abdel-Samii
Yaseen A. M. M. Elshaier
spellingShingle Tarek S. Ibrahim
Mohamed M. Hawwas
Azizah M. Malebari
Ehab S. Taher
Abdelsattar M. Omar
Niamh M. O’Boyle
Eavan McLoughlin
Zakaria K. Abdel-Samii
Yaseen A. M. M. Elshaier
Potent Quinoline-Containing Combretastatin A-4 Analogues: Design, Synthesis, Antiproliferative, and Anti-Tubulin Activity
Pharmaceuticals
combretastatin A-4
quinoline
tubulin
apoptosis
hydrazone
oxadiazole
author_facet Tarek S. Ibrahim
Mohamed M. Hawwas
Azizah M. Malebari
Ehab S. Taher
Abdelsattar M. Omar
Niamh M. O’Boyle
Eavan McLoughlin
Zakaria K. Abdel-Samii
Yaseen A. M. M. Elshaier
author_sort Tarek S. Ibrahim
title Potent Quinoline-Containing Combretastatin A-4 Analogues: Design, Synthesis, Antiproliferative, and Anti-Tubulin Activity
title_short Potent Quinoline-Containing Combretastatin A-4 Analogues: Design, Synthesis, Antiproliferative, and Anti-Tubulin Activity
title_full Potent Quinoline-Containing Combretastatin A-4 Analogues: Design, Synthesis, Antiproliferative, and Anti-Tubulin Activity
title_fullStr Potent Quinoline-Containing Combretastatin A-4 Analogues: Design, Synthesis, Antiproliferative, and Anti-Tubulin Activity
title_full_unstemmed Potent Quinoline-Containing Combretastatin A-4 Analogues: Design, Synthesis, Antiproliferative, and Anti-Tubulin Activity
title_sort potent quinoline-containing combretastatin a-4 analogues: design, synthesis, antiproliferative, and anti-tubulin activity
publisher MDPI AG
series Pharmaceuticals
issn 1424-8247
publishDate 2020-11-01
description A novel series of quinoline derivatives of combretastatin A-4 incorporating rigid hydrazone and a cyclic oxadiazole linkers were synthesized and have demonstrated potent tubulin polymerization inhibitory properties. Many of these novel derivatives have shown significant antiproliferative activities in the submicromolar range. The most potent compound,<b> 19h</b>, demonstrated superior IC<sub>50</sub> values ranging from 0.02 to 0.04 µM against four cancer cell lines while maintaining low cytotoxicity in MCF-10A non-cancer cells, thereby suggesting <b>19h</b>’s selectivity towards proliferating cancer cells. In addition to tubulin polymerization inhibition, <b>19h </b>caused cell cycle arrest in MCF-7 cells at the G2/M phase and induced apoptosis. Collectively, these findings indicate that <b>19h</b> holds potential for further investigation as a potent chemotherapeutic agent targeting tubulin.
topic combretastatin A-4
quinoline
tubulin
apoptosis
hydrazone
oxadiazole
url https://www.mdpi.com/1424-8247/13/11/393
work_keys_str_mv AT tareksibrahim potentquinolinecontainingcombretastatina4analoguesdesignsynthesisantiproliferativeandantitubulinactivity
AT mohamedmhawwas potentquinolinecontainingcombretastatina4analoguesdesignsynthesisantiproliferativeandantitubulinactivity
AT azizahmmalebari potentquinolinecontainingcombretastatina4analoguesdesignsynthesisantiproliferativeandantitubulinactivity
AT ehabstaher potentquinolinecontainingcombretastatina4analoguesdesignsynthesisantiproliferativeandantitubulinactivity
AT abdelsattarmomar potentquinolinecontainingcombretastatina4analoguesdesignsynthesisantiproliferativeandantitubulinactivity
AT niamhmoboyle potentquinolinecontainingcombretastatina4analoguesdesignsynthesisantiproliferativeandantitubulinactivity
AT eavanmcloughlin potentquinolinecontainingcombretastatina4analoguesdesignsynthesisantiproliferativeandantitubulinactivity
AT zakariakabdelsamii potentquinolinecontainingcombretastatina4analoguesdesignsynthesisantiproliferativeandantitubulinactivity
AT yaseenammelshaier potentquinolinecontainingcombretastatina4analoguesdesignsynthesisantiproliferativeandantitubulinactivity
_version_ 1724422567878459392